Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

115.26
Delayed Data
As of Aug 26
 +0.49 / +0.43%
Today’s Change
66.57
Today|||52-Week Range
118.92
+45.94%
Year-to-Date
'Mad Money' Lightning Round: Buy Edwards Lifesciences, Five Below
Aug 25 / TheStreet.com - Paid Partner Content
FDA OKs Edwards Lifesciences' Sapien 3 for Extended Use
Aug 19 / Zacks.com - Paid Partner Content
Edwards Lifesciences: Rallies on Strong THV Sales, View Up
Aug 22 / Zacks.com - Paid Partner Content
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Aug 17 / Zacks.com - Paid Partner Content
Stock Market News for August 19, 2016
Aug 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close114.77
Today’s open114.87
Day’s range114.41 - 115.86
Volume978,114
Average volume (3 months)1,575,454
Market cap$24.5B
Dividend yield--
Data as of 4:02pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-39.84%
Earnings growth (this year)+25.77%
Earnings growth (next 5 years)+17.50%
Revenue growth (last year)+7.35%
P/E ratio47.6
Price/Sales6.98
Price/Book9.92

Competitors

 Today’s
change
Today’s
% change
ISRGIntuitive Surgical-1.16-0.17%
SNNSmith & Nephew PLC+0.25+0.76%
SYKStryker Corp+1.13+1.00%
STESTERIS plc+0.54+0.78%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 24, 2016
EPS forecast (this quarter)$0.67
Annual revenue (last year)$2.5B
Annual profit (last year)$494.9M
Net profit margin19.85%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts

Partner Offers

Search for Jobs